Apellis Pharmaceuticals, Inc. - Common Stock (NQ:APLS)
Price and Volume
Detailed Quote| Volume | 2,883,441 |
| Open | 20.32 |
| Bid (Size) | 19.83 (1,700) |
| Ask (Size) | 19.87 (2,700) |
| Prev. Close | 20.16 |
| Today's Range | 19.55 - 20.32 |
| 52wk Range | 16.10 - 30.48 |
| Shares Outstanding | 116,457,008 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Apellis Pharmaceuticals to Participate in Upcoming Investor Conferences
November 25, 2025
These stocks are moving in today's session ↗
October 30, 2025
Here are the top movers in Thursday's session. ↗
October 30, 2025
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
October 30, 2025
Frequently Asked Questions
Is Apellis Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Apellis Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Apellis Pharmaceuticals, Inc. - Common Stock trade on?
Apellis Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Apellis Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Apellis Pharmaceuticals, Inc. - Common Stock is APLS on the Nasdaq Stock Market
What is the current price of Apellis Pharmaceuticals, Inc. - Common Stock?
The current price of Apellis Pharmaceuticals, Inc. - Common Stock is 19.86
When was Apellis Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Apellis Pharmaceuticals, Inc. - Common Stock was at 03/04/26 04:00 PM ET
What is the market capitalization of Apellis Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Apellis Pharmaceuticals, Inc. - Common Stock is 2.31B
How many shares of Apellis Pharmaceuticals, Inc. - Common Stock are outstanding?
Apellis Pharmaceuticals, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.